According to the World Health Organization (WHO), worldwide human obesity has nearly tripled since 1975, with more than 1.9 billion adults classed as overweight and 650 million of these being obese.
In parallel, pet obesity is on the rise too. The US Association for Pet Obesity Prevention (APOP) has stated that up to 59% of dogs and cats are overweight, with recent studies suggesting that approximately 21% of canines are classed as overweight 6 months after birth.
Bjørn Liaset, Director of R&D at Biomega, said: “With global obesity levels in humans and animals rising year-on-year, there is a growing demand for functional food ingredients that have demonstrated their efficacy to help manage weight through safe, secure and science-backed studies."
“Our whitepaper explores how salmon protein hydrolysates can help to manage weight and combat health conditions relating to obesity in humans and animals."
"Considering substantial scientific evidence and reference to several published studies, the document outlines how bioactive salmon peptides can theoretically reduce inflammation in visceral adipose tissue and significantly decrease body mass index.”
Entitled, "Salmon Peptides and Their Potential Role in Weight Management," the whitepaper is the second in a series of releases from Biomega explaining the scientific advantages salmon bioactive peptides could have on human and animal well-being.
The whitepaper, which follows the company’s first document on cardiovascular health, is available to download for free by completing the website form.
“As leaders in the biosciences industry, it’s critical that we use this science-backed evidence to positively contribute to the wellbeing of humans and animals,” Marianne Warnaer, Director of Global Sales at Biomega, adds.
“Biomega is working with key industry players and brands to deliver safe and trusted salmon peptides to not only help improve the quality of life, but to prevent further health complications. With our sustainable food ingredients, we value vitality, value today and value tomorrow.”
